Benign prostatic hyperplasia. Part 2--management.
作者信息
Wilt Timothy J, N'Dow James
机构信息
Center for Chronic Disease Outcomes Research, 1 Veterans Drive (111-0), Minneapolis, MN 55417, USA.
出版信息
BMJ. 2008 Jan 26;336(7637):206-10. doi: 10.1136/bmj.39433.670718.AD.
Abstract
摘要
相似文献
1
Benign prostatic hyperplasia. Part 2--management.良性前列腺增生。第2部分——管理
BMJ. 2008 Jan 26;336(7637):206-10. doi: 10.1136/bmj.39433.670718.AD.
2
[Modern pharmacotherapy of benign prostatic hyperplasia].[良性前列腺增生的现代药物治疗]
Pol Merkur Lekarski. 2005 Nov;19(113):710-5.
3
Optimising the medical management of benign prostatic hyperplasia.优化良性前列腺增生的药物治疗
Eur Urol. 2004 Apr;45(4):411-9. doi: 10.1016/j.eururo.2003.10.016.
4
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.良性前列腺增生/下尿路症状的药物治疗：执业临床医生概述
BJU Int. 2004 Sep;94(5):738-44. doi: 10.1111/j.1464-410X.2004.05022.x.
5
Combination 5-alpha-reductase inhibitors and alpha-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.5α-还原酶抑制剂与α受体阻滞剂联合用于治疗良性前列腺增生继发的下尿路症状。
Curr Urol Rep. 2008 Jul;9(4):291-4. doi: 10.1007/s11934-008-0051-y.
6
A current review of medical therapy for benign prostatic hyperplasia.良性前列腺增生症药物治疗的现状综述。
J Am Osteopath Assoc. 2004 Feb;104(2 Suppl 2):S11-6.
7
[Epidemiology of BPH and medication approaches].[良性前列腺增生症的流行病学及药物治疗方法]
Ther Umsch. 2006 Feb;63(2):123-8. doi: 10.1024/0040-5930.63.2.123.
8
[Approach to benign hypertrophy of the prostate in primary health care].[基层医疗中前列腺良性增生的处理方法]
Aten Primaria. 1995 Apr 30;15(7):461-4.
9
Noninvasive treatment of benign prostatic hyperplasia. Where do we stand in 2005.良性前列腺增生的非侵入性治疗。2005年我们处于什么水平。
Saudi Med J. 2006 Mar;27(3):299-304.
10
[Modern algorithm of examination and treatment of patients with prostatic adenoma].[前列腺腺瘤患者的现代检查与治疗算法]
Urologiia. 2007 May-Jun(3):87-94.
引用本文的文献
1
Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.羟氯喹啉通过靶向表皮生长因子受体/细胞外信号调节激酶/信号转导与转录激活因子3以及雄激素受体/叉头框蛋白O1/肿瘤坏死因子相关凋亡诱导配体通路调控大鼠实验性诱导的良性前列腺增生的进展：计算机模拟和体内研究
Sci Rep. 2025 Jun 20;15(1):20118. doi: 10.1038/s41598-025-04267-y.
2
Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH).良性前列腺增生 (BPH) 的微创治疗。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231155000. doi: 10.1177/15330338231155000.
3
Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison.基于门诊药物配给和住院 ICD-10 诊断的疾病识别：比较。
BMC Health Serv Res. 2013 Oct 31;13:453. doi: 10.1186/1472-6963-13-453.
4
Benign prostatic hyperplasia: alpha1 adrenoreceptor antagonists and cataract surgery.良性前列腺增生：α1肾上腺素能受体拮抗剂与白内障手术
BMJ. 2008 Feb 9;336(7639):291. doi: 10.1136/bmj.39479.506933.3A.
本文引用的文献
1
WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.撤回：坦索罗辛用于良性前列腺增生。
Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD002081. doi: 10.1002/14651858.CD002081.pub2.
2
Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement.对良性前列腺增生男性手术治疗的有效性和成本效用进行系统评价和经济建模。
Health Technol Assess. 2008 Nov;12(35):iii, ix-x, 1-146, 169-515. doi: 10.3310/hta12350.
3
Five-alpha-reductase Inhibitors for prostate cancer prevention.用于预防前列腺癌的5α-还原酶抑制剂。
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD007091. doi: 10.1002/14651858.CD007091.
4
Benign prostatic hyperplasia. Part 1--diagnosis.良性前列腺增生。第一部分——诊断。
BMJ. 2008 Jan 19;336(7636):146-9. doi: 10.1136/bmj.39421.685023.AE.
5
Microwave thermotherapy for benign prostatic hyperplasia.微波热疗治疗良性前列腺增生症。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD004135. doi: 10.1002/14651858.CD004135.pub2.
6
Self management for men with lower urinary tract symptoms: randomised controlled trial.男性下尿路症状的自我管理：随机对照试验
BMJ. 2007 Jan 6;334(7583):25. doi: 10.1136/bmj.39010.551319.AE. Epub 2006 Nov 21.
7
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.一种用于进一步理解、评估和治疗男性下尿路症状的转变范式：聚焦于膀胱。
Eur Urol. 2006 Apr;49(4):651-8. doi: 10.1016/j.eururo.2006.02.018. Epub 2006 Feb 17.
8
Techniques and long-term results of surgical procedures for BPH.良性前列腺增生症手术治疗的技术与长期疗效
Eur Urol. 2006 Jun;49(6):970-8; discussion 978. doi: 10.1016/j.eururo.2005.12.072. Epub 2006 Feb 6.
9
Saw palmetto for benign prostatic hyperplasia.用于良性前列腺增生的锯叶棕。
N Engl J Med. 2006 Feb 9;354(6):557-66. doi: 10.1056/NEJMoa053085.
10
Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.联合使用α-肾上腺素能拮抗剂和毒蕈碱拮抗剂治疗排尿功能障碍。
J Urol. 2005 Nov;174(5):1743-8. doi: 10.1097/01.ju.0000176460.62847.23.
Zotero 插件